Navigation Links
Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
Date:1/10/2011

(all amounts in millions of dollars) for the full year 2010: Year EndYear EndIncrease12/31/201012/31/2009(Decrease)Testim U.S. Revenue

$190.0$152.025.0%Testim Ex – U.S. & Contract Revenue

3.08.5(64.2%)Total Testim Revenue

$193.0$160.520.3%XIAFLEX U.S. Revenue

$14.1n/an/aXIAFLEX Contract Revenue

4.33.622.1%Total XIAFLEX Revenue

$18.4$3.6416.7%Total Worldwide Revenue

$211.4$164.028.9%Contract Revenues represent amortization of previously received upfront and milestone payments.

2011 XIAFLEX Net Revenue GuidanceFor 2011, Auxilium anticipates that 2011 XIAFLEX net revenues will be in the range of $55.0 to $67.0 million, including approximately $50.0 to 60.0 million in U.S. revenue, and $5.0 to 7.0 million in revenue recognized from royalties and milestones under the Pfizer contract.  

Upcoming Investor PresentationAuxilium reported these numbers in advance of a presentation to investors tomorrow, January 11, 2011 at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, when Auxilium's Chief Executive Officer and President, Armando Anido, will outline the Company's strategic priorities.

Mr. Anido will speak at 4:00 p.m. PT (7:00 p.m. ET) tomorrow, and his remarks will be webcast via a link on the "For Investors" section of www.auxilium.com. Mr. Anido will give an overview of the Auxilium current business strategy, which will focus on the following areas:

  • maximizing the value of Testim and XIAFLEX,
  • delivering on the current pipeline,
  • building out the pipeline in specialty therapeutic areas.

  • A PDF of the presentation slides to be used during the remarks is now available on the "For Investors" section of the Auxilium web site under the "Presentations" tab.  A question and answer session will follow tomorrow's presentation and will also be webcast.  The presentation webcast, the presenta
    '/>"/>

    SOURCE Auxilium Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
    3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
    4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
    5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
    6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
    7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/1/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/63gppw/asian_dermatology ) has announced ... Type, by End User - Forecast to 2019" report ... is estimated to grow at a CAGR of 11.3% from ... larger share in the Dermatology devices market around 28.8% in ... Dermatology Devices market holds a high potential for growth in ...
    (Date:5/1/2015)... 1, 2015 At the American Association of ... Washington D.C. , Elekta will highlight ... clinicians to leverage the enormous amount of data – ... each year – to advance clinical research and further ... a cloud-based solution that allows practitioners to store, retrieve, ...
    (Date:5/1/2015)... Pharmacyclics, Inc. (the "Company") (NASDAQ: PCYC ) today ... 2015, as well as general business updates. Due to ... be held. Key Highlights , Total ... to $206 million from $119 million for the quarter ... (ibrutinib) net product revenue of $247 million was ...
    Breaking Medicine Technology:Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 3Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 26Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 27Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 28Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 29Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 30Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 31Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 32
    ... National Basketball Association (NBA), the Women,s National Basketball Association ... collaboration with the American Diabetes Association and Sanofi US, ... Dribble to Stop Diabetes campaign, a national multimedia ... healthy lifestyle and raise awareness about diabetes prevention, management ...
    ... Md., Jan. 26, 2012  Vanda Pharmaceuticals Inc. (NASDAQ: ... for the first time to reset the body clock ... in patients suffering from Non-24-Hour Sleep-Wake Disorder (Non-24-Hour Disorder).  ... treatment of Non-24-Hour Disorder in totally blind individuals with ...
    Cached Medicine Technology:NBA, American Diabetes Association and Sanofi US Tip Off 2012 Dribble to Stop Diabetes Campaign 2NBA, American Diabetes Association and Sanofi US Tip Off 2012 Dribble to Stop Diabetes Campaign 3NBA, American Diabetes Association and Sanofi US Tip Off 2012 Dribble to Stop Diabetes Campaign 4Initial Clinical Data Reveal Potential of Tasimelteon to Reset the Body Clock in Non-24-Hour Sleep-Wake Disorder 2Initial Clinical Data Reveal Potential of Tasimelteon to Reset the Body Clock in Non-24-Hour Sleep-Wake Disorder 3Initial Clinical Data Reveal Potential of Tasimelteon to Reset the Body Clock in Non-24-Hour Sleep-Wake Disorder 4Initial Clinical Data Reveal Potential of Tasimelteon to Reset the Body Clock in Non-24-Hour Sleep-Wake Disorder 5
    (Date:5/2/2015)... Vancouver fencing company, QS Fencing, has recently ... to prospective clients related to their questions on railings and ... around their decks and patios. While that seems like an ... once the person rolls up their sleeve to start working. ... in finding a gate that matches it. , Instead of ...
    (Date:5/2/2015)... 2015 “ Peachtree Audio ” was ... Report, which features the latest and coolest technology products ... special reporter for NewsWatch, conducted the review and shared ... , Music is an important part of people’s ... and given the royal treatment. Peachtree Audio does just ...
    (Date:5/2/2015)... May 02, 2015 With the success that ... is proud to welcome Neida Miranda and Alex Shields to ... Consulting has over 41 years of combined experience working with ... in the dental field for 8 years. She was ... Waco, Texas. Customer service, positive attitude and showing the importance ...
    (Date:5/1/2015)... Royal River Natural Foods, a locally-owned independent natural ... study that found two natural nutrients, glucosamine and chondroitin, ... as well as standard drug treatment after six months ... The report is part of the May 2015 issue ... Royal River Natural Foods publishes for free each month ...
    (Date:5/1/2015)... May 01, 2015 Ernst & Young ... Joshua Rosenthal, Co-Founder & CSO, and Burak Sezen, Co-Founder ... the EY Entrepreneur Of The Year® 2015 Awards ... Young is a global leader in assurance, tax, ... be one of the top audit companies in the ...
    Breaking Medicine News(10 mins):Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
    ... ... Surgery indicate breast augmentation has surpassed liposuction after years of dominance as the number-one ... Straka makes breast surgery procedures a main focus of his practice, in addition to ... , ...
    ... ... in new grants to assist Medicare beneficiaries in need of information on a wide ... ... 2009 -- In an effort to assist California Medicare beneficiaries to obtain better, more ...
    ... Susan Lark, MD, ... searchhearthealth.com, a new informational Web site devoted to all aspects of heart health. , ... Potomac, MD (Vocus) July 20, 2009 ... is now a featured expert on searchhearthealth.com, a new informational Web site devoted to all ...
    ... July 21 Following is the daily "Profile America" feature ... http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) , , ... - Tuesday, July 21st. On the one hand, there,s ... diet of many Americans, underlined by pronouncements of anxiety from ...
    ... , , , ... ) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from ... Application (ANDA) for Haloperidol Tablets USP, 10 mg and 20 mg. These strengths ... and 5 mg strengths of the product. , , ...
    ... therapies should be the standard of care for all HIV-infected ... resources, according to a study led by researchers at Massachusetts ... of Cape Town, South Africa. The team reports in ... starting antiretroviral therapy (ART) when the level of CD4 ...
    Cached Medicine News:Health News:Nation's Most Popular Cosmetic Surgery Procedure is a Way for One Houston Plastic Surgeon to Renew Body Contours and Self-Esteem 2Health News:Nation's Most Popular Cosmetic Surgery Procedure is a Way for One Houston Plastic Surgeon to Renew Body Contours and Self-Esteem 3Health News:California Health Insurance Assistance Program Awarded 2009 Grant Funding, Says MedicareSupplementPlans.com 2Health News:Women's Health Expert Dr. Susan Lark Featured on Searchhearthealth.com 2Health News:Earlier HIV antiviral treatment can be cost effective in areas of limited resources 2
    ... remote monitoring service allows the the ... monitored from any location via modem ... enhances preventive maintenance capabilities. Thermo ... unit (with your permission) from their ...
    Shandon HistoWave is the answer to rapid tissue processing. It reduces time for fixation, tissue processing, decalification, immunochemistry and special stains....
    ... Grossing Wokrstation is a durable, safety-driven, ... gross examination and sectioning of specimens. ... efficient ventilation systems and options of ... faucets, table rinses, disposals and dictation ...
    The Shandon Grosslab Grossing Workstation comes in a bench top or stand alone design for the gross examination and sectioning of specimens....
    Medicine Products: